522 The ability of NSAIDs to inhibit polyp formation and stimulate Type I immunity is dose dependent
Marquez-Manriquez, J.P, Kim, R, Rastetter, L, Gad, E, Disis, M.L
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
Serum antibodies recognizing hypoxia-inducible factor 1-alpha and platinum sensitivity in ovarian cancer
Agnew, K.J, Swisher, E.M, Goff, B.A, Disis, M.L, Liao, J.B
Published in Gynecologic oncology (01.06.2014)
Published in Gynecologic oncology (01.06.2014)
Get full text
Journal Article
2749 Avelumab (MSB0010718C), an anti-PD-L1 antibody, in patients with recurrent or refractory ovarian cancer: A phase Ib trial reporting safety and clinical activity
Disis, M.L, Patel, M, Pant, S, Hamilton, E.P, Lockhart, A.C, Kelly, K, Thaddeus-Beck, J, Gordon, M, Weiss, G.J, Ejadi, S, Taylor, M.H, Chin, K, Cuillerot, J.M, Von Heydebreck, A, Gulley, J.L
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
2011 Multi-antigen vaccination for colon cancer treatment and prevention
Marquez-Manriquez, J.P, Ramos, E, Durazo-Bustamante, F, Rastetter, L, Koehnlein, M, Brooussard, E, Coveler, A, Kim, R, Childs, J, Gad, E, Disis, M.L
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
Phase 1b Trial of TLR8 Agonist VTX-2337 in Combination With Cetuximab in Patients With Recurrent or Metastatic Squamous Cell Carcinomas of the Head and Neck (SCCHN)
Chow, L.Q.M, Eaton, K.D, Baik, C, Goulart, B, Morishima, C, Disis, M.L, Manjarrez, K, Dietsch, G, Hershberg, R, Martins, R.G
Published in International journal of radiation oncology, biology, physics (01.02.2014)
Published in International journal of radiation oncology, biology, physics (01.02.2014)
Get full text
Journal Article
Serum antibodies recognizing BRCA1 at time of diagnosis and primary platinum resistance in ovarian cancer
Ovenell, K.J, Wu, M, Agnew, K.J, Harrell, M.I, Swisher, E.M, Goff, B.A, Disis, M.L
Published in Gynecologic oncology (01.06.2014)
Published in Gynecologic oncology (01.06.2014)
Get full text
Journal Article
A phase I trial of a DNA plasmid-based vaccine targeting insulin-like growth factor binding protein-2 (IGFBP-2) in patients with advanced ovarian cancer: Preliminary safety and immunogenicity
Cecil, D.L, Reichow, J, Parker, S, Higgins, D, Childs, J, Broussard, E, Coveler, A, Salazar, L, Disis, M.L
Published in Gynecologic oncology (01.06.2014)
Published in Gynecologic oncology (01.06.2014)
Get full text
Journal Article
Therapeutic cancer vaccines revamping: technology advancements and pitfalls
Antonarelli, G., Corti, C., Tarantino, P., Ascione, L., Cortes, J., Romero, P., Mittendorf, E.A., Disis, M.L., Curigliano, G.
Published in Annals of oncology (01.12.2021)
Published in Annals of oncology (01.12.2021)
Get full text
Journal Article